(Press-News.org) Women are under-represented in academic medicine resulting in a waste of public investment due to loss of research talent. Writing in the July issue of the Journal of the Royal Society of Medicine, authors of an essay on women and academic medicine say that as a consequence of female under-representation, some areas of medicine are under-researched at a cost to patients and society. Discriminatory practices and unconscious bias, they say, continue to occur in academic medicine, despite a substantial fall in traditional discrepancies between men and women in medicine in recent years. The proportion of women entering medical school today is around 53%.
"There has been a longstanding gender imbalance in clinical academia as well as laboratory-based basic medical sciences", said lead author Professor Jonathan Grant, Director of the Policy Institute at King's College London. "This inequality increases substantially with seniority, with women representing only 15% of professors in UK medical schools."
Chief Medical Officer Professor Dame Sally Davies, a co-author of the essay, said: "The lack of women participating in the clinical academic research system is likely to be implicitly biasing today's research agenda and, by consequence, tomorrow's clinical practice." She added: "The system needs to be reformed by medical schools improving the culture for and chances of women in clinical academia, through schemes such as Athena Swan. The adoption and embedding of gender neutral policies, for example flexible working, will be of benefit to all clinical academics whether women or men."
INFORMATION:
Notes to Editors
Women and academic medicine: a review of the evidence on female representation (DOI: 10.1177/0141076814528893) by Maryse Penny, Rosanna Jeffries, Jonathan Grant and Sally C. Davies will be published by the Journal of the Royal Society of Medicine at 00:05hrs (UK time) on Friday 11 July 2014.
The JRSM is the flagship journal of the Royal Society of Medicine and is published by SAGE. It has full editorial independence from the RSM. It has been published continuously since 1809. Its Editor is Dr Kamran Abbasi.
SAGE is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine.
Women under-represented in academic medicine
2014-07-11
ELSE PRESS RELEASES FROM THIS DATE:
Heart health benefits of light drinking brought into question
2014-07-11
A reduction in alcohol consumption, even for light-to-moderate drinkers, could be linked to improved cardiovascular health, including a reduced risk of coronary heart disease, lower body mass index and blood pressure, according to new research published in The BMJ.
These latest findings challenge the results of previous observational studies which found that the consumption of light-to-moderate amounts of alcohol (12-25 units per week) may have a protective effect on cardiovascular health.
The research, led by the London School of Hygiene & Tropical Medicine with University ...
Injected vaccine could help eradicate polio
2014-07-11
Re-introducing a type of polio vaccine that fell out of favour in the 1960s could hasten eradication of the disease, according to new research.
The study, by Imperial College London and the Christian Medical College in Vellore, India, suggests that the injected polio vaccine (IPV), which is rarely used today in countries affected by polio, could provide better and longer lasting protection against infection if used in combination with the more commonly used live oral polio vaccine (OPV).
The findings are published today in The Lancet.
Vaccination protects an individual ...
The Lancet: World's most advanced dengue vaccine candidate shows promise in phase 3 trial
2014-07-11
The first dengue vaccine candidate (CYD-TDV) to reach phase 3 clinical testing has shown moderate protection (56%) against the disease in Asian children, according to new research published in The Lancet.
Dengue is a mosquito-borne disease that infects around 390 million people each year, of whom about 96 million suffer from symptomatic infection. WHO estimates that the global burden of dengue has risen 30-fold over the past 50 years, with over half of the world's population at risk of the disease.
There is no licensed vaccine available to treat or prevent dengue ...
The Lancet: Extra dose of inactivated polio vaccine boosts immunity in children and could speed up global eradication efforts
2014-07-11
Giving children under 5 years old an extra dose of inactivated polio vaccine (IPV) helps to boost their immunity to the poliovirus and should be added to vaccination programmes in polio-endemic countries and those facing a high risk of imported cases, suggests new research published in The Lancet.
Lead author Dr Jacob John from Christian Medical College, India explains, "Adding a supplementary IPV dose to children already vaccinated with oral poliovirus vaccine (OPV) may hasten polio eradication by boosting herd immunity in endemic regions, act as a booster to prevent ...
The Lancet: Novel treatment for drug-resistant tuberculosis shows promise, but concerns for patient safety remain
2014-07-11
In a viewpoint published this week in The Lancet, the Community Research Advisors Group (CRAG) argue that research into bedaquiline – a new drug, fast tracked for multidrug-resistant tuberculosis (MDR-TB) – should proceed cautiously in people with drug-sensitive tuberculosis. CRAG, an international, community-based advisory board for the US Centers for Disease Control and Prevention's Tuberculosis Trials Consortium, writing in The Lancet independently, urge researchers to balance the goal of shortening treatment for drug-sensitive TB with patient safety.
Bedaquiline ...
Cost of expensive medication in dialysis catheters may be offset by reduced complications
2014-07-11
Washington, DC (July 10, 2014) — Using an expensive agent to prevent blood clots in kidney failure patients' dialysis catheters may turn out to be less costly overall due to its ability to reduce medical complications, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Recombinant tissue plasminogen activator (rt-PA) is a medication used to break up blood clots that occur in the vessels of patients having a heart attack. A recent clinical trial revealed that using rt-PA once per week plus the anticlotting agent ...
High stress, hostility, depression linked with increased stroke risk
2014-07-10
Higher levels of stress, hostility and depressive symptoms are associated with significantly increased risk of stroke or transient ischemic attack (TIA) in middle-age and older adults, according to new research in the American Heart Association journal Stroke.
A TIA is a stroke caused by a temporary blockage of blood flow to the brain.
Researchers investigated how psychological factors might influence risk for chronic disease, using data from the Multi-Ethnic Study of Atherosclerosis (MESA), an ongoing study on cardiovascular disease risk factors in participants living ...
After a concussion, which teens will have emotional symptoms?
2014-07-10
CHICAGO – After a concussion, teens who are sensitive to light or noise may be more likely to also have emotional symptoms such as anxiety, according to a study released today that will be presented at The Sports Concussion Conference in Chicago, July 11 to 13, 2014, hosted by the American Academy of Neurology, the world's leading authority on diagnosing and managing sports concussion. The conference will feature the latest scientific advances in diagnosing and treating sports concussion from leading experts in the field.
The symptoms after a concussion can vary widely ...
Neutron crystallography solves long-standing biological mystery
2014-07-10
The controversy centres around a family of enzymes known as heme enzymes, due to the presence of a heme group in their active site. At the centre of the heme cofactor is an iron (Fe) atom, which becomes oxidised (ferryl) when a reacting heme is in an intermediate state called Compound I. The question that has remained unanswered for decades is whether this oxidation involves just an oxygen atom (O), or a hydroxyl group (OH). Resolving this fundamental question has implications for understanding oxidative processes within living cells, which is critically important for drug ...
Astronomers find 7 dwarf galaxies with new telescope
2014-07-10
Meet the seven new dwarf galaxies.
Yale University astronomers, using a new type of telescope made by stitching together telephoto lenses, recently discovered seven celestial surprises while probing a nearby spiral galaxy. The previously unseen galaxies may yield important insights into dark matter and galaxy evolution, while possibly signaling the discovery of a new class of objects in space.
For now, scientists know they have found a septuplet of new galaxies that were previously overlooked because of their diffuse nature: The ghostly galaxies emerged from the night ...